NEW YORK (GenomeWeb News) – Life Technologies said today that it has formed a translational research collaboration with the University of Cambridge that will enable researchers to use the firm’s sequencing technologies through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.
Under the collaboration, European researchers studying cancer, diabetes, and other disorders will be able to use three SOLiD 3 Plus Systems for next generation targeted resequencing and whole transcriptome analysis studies.